IFRS 7 — Financial Instruments: Disclosures
IFRS 7 Financial Instruments: Disclosures requires disclosure of information about the significance of financial instruments to an entity, and the nature and extent of risks arising from those financial instruments, both in qualitative and quantitative terms. Specific disclosures are required in relation to transferred financial assets and a number of other matters.
IFRS 7 was originally issued in August 2005 and applies to annual periods beginning on or after 1 January 2007.
History of IFRS 7
|22 July 2004||Exposure Draft ED 7 Financial Instruments: Disclosures published||Comment deadline 14 September 2009|
|18 August 2005||IFRS 7 Financial Instruments: Disclosures issued||Effective for annual periods beginning on or after 1 January 2007|
|22 May 2008||Amended by Improvements to IFRSs (required disclosures when interests in jointly controlled entities are accounted for at fair value through profit or loss, presentation of finance costs)||Effective for annual periods beginning on or after 1 January 2009|
|13 October 2008||Reclassification of Financial Assets (Amendments to IAS 39 and IFRS 7) issued||Effective 1 July 2008|
|23 December 2008||Exposure Draft Investments in Debt Instruments (Proposed Amendments to IFRS 7) published||Comment deadline 15 January 2009
(Project subsequently abandoned in January 2009)
|5 March 2009||Improving Disclosures about Financial Instruments (Amendments to IFRS 7) issued||Effective for annual periods beginning on or after 1 January 2009|
|6 May 2010||Amended by Improvements to IFRSs (clarification of disclosures)||Effective for annual periods beginning on or after 1 January 2011|
|7 October 2010||Disclosures – Transfers of Financial Assets (Amendments to IFRS 7) issued||Effective for annual periods beginning on or after 1 July 2011|
|16 December 2011||Disclosures — Offsetting Financial Assets and Financial Liabilities (Amendments to IFRS 7) issued||Effective for annual periods beginning on or after 1 January 2013|
|16 December 2011||Mandatory Effective Date and Transition Disclosures (Amendments to IFRS 9 and IFRS 7) issued||Effective for annual periods beginning on or after 1 January 2015 (or otherwise when IFRS 9 is first applied)*|
|19 November 2013||IFRS 9 Financial Instruments (Hedge Accounting and amendments to IFRS 9, IFRS 7 and IAS 39) issued, implementing additional disclosures (and consequential amendments) resulting from the introduction of the hedge accounting chapter in IFRS 9||Applies when IFRS 9 is applied*|
* The release of IFRS 9 Financial Instruments (2013) on 19 November 2013 contained no stated effective date and contained consequential amendments which removed the mandatory effective date of IFRS 9 (2010) and IFRS 9 (2009), leaving the effective date open but leaving each standard available for application. Accordingly, these amendments apply when IFRS 9 is applied.
Amendments under consideration by IASB
Summary of IFRS 7
Overview of IFRS 7
- adds certain new disclosures about financial instruments to those currently required by IAS 32;
- replaces the disclosures previously required by IAS 30; and
- puts all of those financial instruments disclosures together in a new standard on Financial Instruments: Disclosures. The remaining parts of IAS 32 deal only with financial instruments presentation matters.
Disclosure requirements of IFRS 7
IFRS requires certain disclosures to be presented by category of instrument based on the IAS 39 measurement categories. Certain other disclosures are required by class of financial instrument. For those disclosures an entity must group its financial instruments into classes of similar instruments as appropriate to the nature of the information presented. [IFRS 7.6]
The two main categories of disclosures required by IFRS 7 are:
- information about the significance of financial instruments.
- information about the nature and extent of risks arising from financial instruments
Information about the significance of financial instruments
Statement of financial position
- Disclose the significance of financial instruments for an entity's financial position and performance. [IFRS 7.7] This includes disclosures for each of the following categories: [IFRS 7.8]
- financial assets measured at fair value through profit and loss, showing separately those held for trading and those designated at initial recognition
- held-to-maturity investments
- loans and receivables
- available-for-sale assets
- financial liabilities at fair value through profit and loss, showing separately those held for trading and those designated at initial recognition
- financial liabilities measured at amortised cost
- Other balance sheet-related disclosures:
- special disclosures about financial assets and financial liabilities designated to be measured at fair value through profit and loss, including disclosures about credit risk and market risk, changes in fair values attributable to these risks and the methods of measurement.[IFRS 7.9-11]
- reclassifications of financial instruments from one category to another (e.g. from fair value to amortised cost or vice versa) [IFRS 7.12-12A]
- information about financial assets pledged as collateral and about financial or non-financial assets held as collateral [IFRS 7.14-15]
- reconciliation of the allowance account for credit losses (bad debts) by class of financial assets[IFRS 7.16]
- information about compound financial instruments with multiple embedded derivatives [IFRS 7.17]
- breaches of terms of loan agreements [IFRS 7.18-19]
Statement of comprehensive income
- Items of income, expense, gains, and losses, with separate disclosure of gains and losses from: [IFRS 7.20(a)]
- financial assets measured at fair value through profit and loss, showing separately those held for trading and those designated at initial recognition.
- held-to-maturity investments.
- loans and receivables.
- available-for-sale assets.
- financial liabilities measured at fair value through profit and loss, showing separately those held for trading and those designated at initial recognition.
- financial liabilities measured at amortised cost.
- Other income statement-related disclosures:
- total interest income and total interest expense for those financial instruments that are not measured at fair value through profit and loss [IFRS 7.20(b)]
- fee income and expense [IFRS 7.20(c)]
- amount of impairment losses by class of financial assets [IFRS 7.20(e)]
- interest income on impaired financial assets [IFRS 7.20(d)]
- Accounting policies for financial instruments [IFRS 7.21]
- Information about hedge accounting, including: [IFRS 7.22]
- description of each hedge, hedging instrument, and fair values of those instruments, and nature of risks being hedged
- for cash flow hedges, the periods in which the cash flows are expected to occur, when they are expected to enter into the determination of profit or loss, and a description of any forecast transaction for which hedge accounting had previously been used but which is no longer expected to occur
- if a gain or loss on a hedging instrument in a cash flow hedge has been recognised in other comprehensive income, an entity should disclose the following: [IAS 7.23]
- the amount that was so recognised in other comprehensive income during the period
- the amount that was removed from equity and included in profit or loss for the period
- the amount that was removed from equity during the period and included in the initial measurement of the acquisition cost or other carrying amount of a non-financial asset or non- financial liability in a hedged highly probable forecast transaction
Note: Where IFRS 9 Financial Instruments (2013) is applied, revised disclosure requirements apply. The required hedge accounting disclosures apply where the entity elects to adopt hedge accounting and require information to be provided in three broad categories: (1) the entity’s risk management strategy and how it is applied to manage risk (2) how the entity’s hedging activities may affect the amount, timing and uncertainty of its future cash flows, and (3) the effect that hedge accounting has had on the entity’s statement of financial position, statement of comprehensive income and statement of changes in equity. The disclosures are required to be presented in a single note or separate section in its financial statements, although some information can be incorporated by reference.
- For fair value hedges, information about the fair value changes of the hedging instrument and the hedged item [IFRS 7.24(a)]
- Hedge ineffectiveness recognised in profit and loss (separately for cash flow hedges and hedges of a net investment in a foreign operation) [IFRS 7.24(b-c)]
- Information about the fair values of each class of financial asset and financial liability, along with: [IFRS 7.25-30]
- comparable carrying amounts
- description of how fair value was determined
- the level of inputs used in determining fair value
- reconciliations of movements between levels of fair value measurement hierarchy additional disclosures for financial instruments whose fair value is determined using level 3 inputs including impacts on profit and loss, other comprehensive income and sensitivity analysis
- information if fair value cannot be reliably measured
The fair value hierarchy introduces 3 levels of inputs based on the lowest level of input significant to the overall fair value (IFRS 7.27A-27B):
- Level 1 – quoted prices for similar instruments
- Level 2 – directly observable market inputs other than Level 1 inputs
- Level 3 – inputs not based on observable market data
Note that disclosure of fair values is not required when the carrying amount is a reasonable approximation of fair value, such as short-term trade receivables and payables, or for instruments whose fair value cannot be measured reliably. [IFRS 7.29(a)]
Nature and extent of exposure to risks arising from financial instruments
Qualitative disclosures [IFRS 7.33]
- The qualitative disclosures describe:
- risk exposures for each type of financial instrument
- management's objectives, policies, and processes for managing those risks
- changes from the prior period
- The quantitative disclosures provide information about the extent to which the entity is exposed to risk, based on information provided internally to the entity's key management personnel. These disclosures include: [IFRS 7.34]
- summary quantitative data about exposure to each risk at the reporting date
- disclosures about credit risk, liquidity risk, and market risk and how these risks are managed as further described below
- concentrations of risk
- Credit risk is the risk that one party to a financial instrument will cause a loss for the other party by failing to pay for its obligation. [IFRS 7. Appendix A]
- Disclosures about credit risk include: [IFRS 7.36-38]
- maximum amount of exposure (before deducting the value of collateral), description of collateral, information about credit quality of financial assets that are neither past due nor impaired, and information about credit quality of financial assets whose terms have been renegotiated [IFRS 7.36]
- for financial assets that are past due or impaired, analytical disclosures are required [IFRS 7.37]
- information about collateral or other credit enhancements obtained or called [IFRS 7.38]
- Liquidity risk is the risk that an entity will have difficulties in paying its financial liabilities. [IFRS 7. Appendix A]
- Disclosures about liquidity risk include: [IFRS 7.39]
- a maturity analysis of financial liabilities
- description of approach to risk management
Market risk [IFRS 7.40-42]
- Market risk is the risk that the fair value or cash flows of a financial instrument will fluctuate due to changes in market prices. Market risk reflects interest rate risk, currency risk and other price risks. [IFRS 7. Appendix A]
- Disclosures about market risk include:
- a sensitivity analysis of each type of market risk to which the entity is exposed
- additional information if the sensitivity analysis is not representative of the entity's risk exposure (for example because exposures during the year were different to exposures at year-end).
- IFRS 7 provides that if an entity prepares a sensitivity analysis such as value-at-risk for management purposes that reflects interdependencies of more than one component of market risk (for instance, interest risk and foreign currency risk combined), it may disclose that analysis instead of a separate sensitivity analysis for each type of market risk
Transfers of financial assets [IFRS 7.42A-H]
An entity shall disclose information that enables users of its financial statements:
- to understand the relationship between transferred financial assets that are not derecognised in their entirety and the associated liabilities; and
- to evaluate the nature of, and risks associated with, the entity's continuing involvement in derecognised financial assets. [IFRS 7 42B]
Transferred financial assets that are not derecognised in their entirety
- Required disclosures include description of the nature of the transferred assets, nature of risk and rewards as well as description of the nature and quantitative disclosure depicting relationship between transferred financial assets and the associated liabilities. [IFRS 7.42D]
Transferred financial assets that are derecognised in their entirety
- Required disclosures include the carrying amount of the assets and liabilities recognised, fair value of the assets and liabilities that represent continuing involvement, maximum exposure to loss from the continuing involvement as well as maturity analysis of the undiscounted cash flows to repurchase the derecognised financial assets. [IFRS 7.42E]
- Additional disclosures are required for any gain or loss recognised at the date of transfer of the assets, income or expenses recognise from the entity's continuing involvement in the derecognised financial assets as well as details of uneven distribution of proceed from transfer activity throughout the reporting period. [IFRS 7.42G]
An appendix of mandatory application guidance (Appendix B) is part of the standard.
There is also an appendix of non-mandatory implementation guidance (Appendix C) that describes how an entity might provide the disclosures required by IFRS 7.